New breast cancer test under study

	Tweet

Whether a painless, portable device that uses electrical current rather than X-ray to look for breast cancer could be an alternative to traditional mammograms is under study at the Medical College of Georgia.

MCG is one of 20 centers internationally and the only place in Georgia studying new technology developed by Z-Tech Inc., to compare traditional mammograms with impedence scanning, a technique based on evidence that electrical current passes through cancerous tissue differently than through normal tissue.

This phase of the study will focus on women age 40-50. Older women have less dense breast tissue so cancer is easier to find, says Dr. James Craft, MCG radiologist and principal investigator on the study. Mammograms, also performed in the study, are more accurate in this population, so this phase will be a tougher test of the new technology, he says. The first phase of the study, which began in 2005, was open to women of all ages. 

“Normal breast tissue is very dense, especially in younger women, and can hide tumors,” Dr. Craft says. “While we’ve known for a while that water flows more freely through cancerous cells, we also know that electrical current flows easier through cancerous and tumor tissue.”

The Z-Tech scan works by placing a flower-shaped grouping of electrodes over each breast and sending a small, painless amount of electricity through them. Unlike traditional mammography, the scan does not involve breast compression or radiation.

“It’s like doing an EKG of the breast,” Dr. Craft says.

A computer immediately calculates and presents a report based on the electrical signature of the breast tissue. Rather than waiting on breast image from a traditional mammogram, the computer immediately notes whether the scan is positive or negative for cancer.

However, for study purposes, neither Dr. Craft nor the patient will know the results. Patients must undergo a mammogram within 90 days, which Dr. Craft interprets. Z-Tech compares those results to the electrical study.

The hope is that the new test – called HEDA for Homologous Electrical Difference Analysis – will provide an alternative to mammograms. While Dr. Craft believes that having this test should help find more cancers, he doesn’t think it will replace traditional mammography.

“This method doesn’t use radiation, is portable and there is no pain associated with the squeezing that mammograms require,” he says. “I can see it being used as an additional test. I don’t think it will replace mammography, but it could increase our chances of catching breast cancer.”

The second phase of the Z-Tech trial is open to women age 40-50 having routine mammograms as well as those who have a suspicious lump scheduled for biopsy.

For more information, call Charlene Weathers, nurse, study coordinator and sub-investigator at 706-721-9437 or 706-721-9680.

Media Contacts

Toni Baker
706-721-4421
Schools of Graduate Studies and Medicine
Research and faculty news

Jennifer Hilliard
706-721-8604
School of Medicine
Research and faculty news

Amy Connell
706-721-8605
Student and Educational News

Paula Hinely
706-721-3646
Schools of Allied Health Sciences, Dentistry and Nursing
Research and faculty news

RELATED STORIES:
Some women worry too much about breast cancer returning, U-M study finds   Breast Cancer - MRI Does Not Help, Even Though Usage Grows   Breast implants may be linked to rare cancer: FDA   Digital mammogram best for younger women: study   Online prayer may benefit breast cancer patients   Study Finds Lapatinib Shows Promise as Therapy for Inflammatory Breast Cancer   Circulating tumor cells predicted recurrence, death in patients with early-stage breast cancer   Personality-breast cancer link debunked   Estrogen receptor-alpha, breast cancer patients and tamoxifen response   Quality of life measures in breast cancer clinical trials   Mammograms May Detect Some Cancers That Would Have Regressed   Scientists developing breast cancer treatment test news   Management and Prognosis: How Best to Treat Breast Cancer Patients   New studies show negative effects from revised mammography recommendation for women, ages 40-49   SNM Releases New Fact Sheet on Breast Cancer and Molecular Imaging   HHS says U.S. policy on mammograms unchanged   Seven quality guidelines for breast, colorectal cancer care   Shortening radiotherapy feasible for breast cancer   Gene helps protect tumor suppressor in breast cancer   Molecular Breast Imaging: A Better Way to Spot Tumors in Dense Tissue   A pill a day gives renewed hope for breast cancer victims   One daily glass of wine ‘can double risk of breast cancer’

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]